ClinConnect ClinConnect Logo
Search / Trial NCT06057181

Helix Research Network

Launched by HELIX, INC · Sep 25, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

The Helix Research Network (HRN) is a study aimed at understanding how our genes can influence our health and the likelihood of developing certain diseases. Researchers from various healthcare organizations are working together to gather and analyze genetic information, which may help improve medical care in the future. This trial is currently looking for participants who are at least 18 years old and are willing to follow the study guidelines.

To be part of this study, individuals must not have had certain types of transplants that could complicate their participation. If you join the study, you can expect to contribute to important research that could lead to better health outcomes for yourself and others. Your involvement will help scientists learn more about how our genetic makeup can affect our health and how this information can be used in everyday medical care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years and older
  • Willing and able to comply with all aspects of the protocol
  • Exclusion Criteria:
  • History of allogenic bone marrow transplant
  • History of allogenic stem cell transplant
  • Anything that would place the individual at increased risk or preclude an individual's: 1) full compliance with study requirements; or 2) completion of the study based on the assessment from local consenting and enrolling Investigators.

About Helix, Inc

Helix, Inc. is a pioneering biotechnology company focused on advancing genomic research and personalized medicine through innovative clinical trials. With a commitment to harnessing the power of genetic data, Helix collaborates with leading research institutions and healthcare organizations to facilitate groundbreaking studies that aim to enhance patient outcomes and drive the development of targeted therapies. By leveraging state-of-the-art sequencing technology and robust data analytics, Helix strives to empower healthcare providers and patients with actionable insights, ultimately transforming the landscape of precision health.

Locations

Bloomington, Minnesota, United States

York, Pennsylvania, United States

Charleston, South Carolina, United States

Houston, Texas, United States

Omaha, Nebraska, United States

Bethlehem, Pennsylvania, United States

Burlington, North Carolina, United States

Sioux Falls, South Dakota, United States

Raleigh, North Carolina, United States

Columbus, Ohio, United States

Patients applied

0 patients applied

Trial Officials

William Lee, PhD

Principal Investigator

Helix, Inc

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported